Eilam Yeini

1.6k total citations
27 papers, 1.1k citations indexed

About

Eilam Yeini is a scholar working on Oncology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Eilam Yeini has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Molecular Biology and 9 papers in Biomedical Engineering. Recurrent topics in Eilam Yeini's work include Nanoplatforms for cancer theranostics (5 papers), RNA Interference and Gene Delivery (4 papers) and Cancer Cells and Metastasis (4 papers). Eilam Yeini is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), RNA Interference and Gene Delivery (4 papers) and Cancer Cells and Metastasis (4 papers). Eilam Yeini collaborates with scholars based in Israel, United States and Portugal. Eilam Yeini's co-authors include Ronit Satchi‐Fainaro, Galia Tiram, Sabina Pozzi, Ron Kleiner, Helena F. Florindo, Lena Neufeld, Yulia Liubomirski, Rita C. Acúrcio, Bárbara Carreira and Daniella Vaskovich‐Koubi and has published in prestigious journals such as Nature Communications, Nature reviews. Cancer and Nature Nanotechnology.

In The Last Decade

Eilam Yeini

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eilam Yeini Israel 14 413 377 276 246 184 27 1.1k
Galia Tiram Israel 17 430 1.0× 568 1.5× 212 0.8× 119 0.5× 181 1.0× 21 1.4k
Joshua C. Doloff United States 19 392 0.9× 824 2.2× 283 1.0× 445 1.8× 104 0.6× 40 1.7k
Weilin Zhou China 19 286 0.7× 435 1.2× 322 1.2× 210 0.9× 88 0.5× 56 1.2k
Mohammad Doroudian Iran 25 267 0.6× 831 2.2× 144 0.5× 297 1.2× 127 0.7× 49 1.6k
Kamal Kant Sharma France 18 126 0.3× 608 1.6× 164 0.6× 124 0.5× 92 0.5× 34 1.3k
Dandan Wan China 11 235 0.6× 360 1.0× 291 1.1× 440 1.8× 59 0.3× 16 919
Yajing Wen China 8 577 1.4× 347 0.9× 114 0.4× 296 1.2× 36 0.2× 12 1.0k
Shiran Ferber Israel 16 416 1.0× 448 1.2× 180 0.7× 194 0.8× 49 0.3× 21 1.1k
Shibing Wang China 24 201 0.5× 721 1.9× 540 2.0× 224 0.9× 66 0.4× 78 1.5k
Yanhong Su China 17 278 0.7× 371 1.0× 202 0.7× 375 1.5× 44 0.2× 48 1.2k

Countries citing papers authored by Eilam Yeini

Since Specialization
Citations

This map shows the geographic impact of Eilam Yeini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eilam Yeini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eilam Yeini more than expected).

Fields of papers citing papers by Eilam Yeini

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eilam Yeini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eilam Yeini. The network helps show where Eilam Yeini may publish in the future.

Co-authorship network of co-authors of Eilam Yeini

This figure shows the co-authorship network connecting the top 25 collaborators of Eilam Yeini. A scholar is included among the top collaborators of Eilam Yeini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eilam Yeini. Eilam Yeini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yeini, Eilam, Shai Dulberg, Ayelet Kaminitz, et al.. (2024). interFLOW: maximum flow framework for the identification of factors mediating the signaling convergence of multiple receptors. npj Systems Biology and Applications. 10(1). 66–66. 2 indexed citations
2.
Yeini, Eilam, et al.. (2024). Abstract 5522: Elucidating the role of P-selectin/P-selectin ligand-1 axis in lung cancer brain metastasis. Cancer Research. 84(6_Supplement). 5522–5522. 1 indexed citations
3.
Dey, Pradip, Ron Kleiner, Sabina Pozzi, et al.. (2024). Two-in-one nanoparticle platform induces a strong therapeutic effect of targeted therapies in P-selectin–expressing cancers. Science Advances. 10(50). eadr4762–eadr4762. 4 indexed citations
4.
Yeini, Eilam, Daniella Vaskovich‐Koubi, Ron Kleiner, Helena F. Florindo, & Ronit Satchi‐Fainaro. (2023). Abstract 3243: Modulating the brain immune system to fight cancer in 3 dimensions. Cancer Research. 83(7_Supplement). 3243–3243. 1 indexed citations
5.
Ofek, Paula, Eilam Yeini, Gali Arad, et al.. (2023). Deoxyhypusine hydroxylase: A novel therapeutic target differentially expressed in short‐term vs long‐term survivors of glioblastoma. International Journal of Cancer. 153(3). 654–668. 6 indexed citations
6.
Yeini, Eilam & Ronit Satchi‐Fainaro. (2022). The role of P-selectin in cancer-associated thrombosis and beyond. Thrombosis Research. 213. S22–S28. 34 indexed citations
7.
Neufeld, Lena, Eilam Yeini, Sabina Pozzi, & Ronit Satchi‐Fainaro. (2022). 3D bioprinted cancer models: from basic biology to drug development. Nature reviews. Cancer. 22(12). 679–692. 80 indexed citations
8.
Arad, Gali, Paula Ofek, Eilam Yeini, et al.. (2021). Proteogenomics of glioblastoma associates molecular patterns with survival. Cell Reports. 34(9). 108787–108787. 34 indexed citations
9.
Yeini, Eilam, Paula Ofek, Sabina Pozzi, et al.. (2021). P-selectin axis plays a key role in microglia immunophenotype and glioblastoma progression. Nature Communications. 12(1). 1912–1912. 56 indexed citations
10.
Vaskovich‐Koubi, Daniella, Ron Kleiner, Yulia Liubomirski, et al.. (2021). Abstract 714: From cancer to COVID-19- development of a dendritic cell-targeted nano-vaccine for prevention and therapy of COVID-19. Cancer Research. 81(13_Supplement). 714–714. 1 indexed citations
11.
Yeini, Eilam, Paula Ofek, Lena Neufeld, et al.. (2020). Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches. Advanced Therapeutics. 4(1). 54 indexed citations
12.
Florindo, Helena F., Ron Kleiner, Daniella Vaskovich‐Koubi, et al.. (2020). Immune-mediated approaches against COVID-19. Nature Nanotechnology. 15(8). 630–645. 249 indexed citations
13.
Blau, Rachel, Dikla Ben‐Shushan, Anat Eldar‐Boock, et al.. (2020). Rational Design of Polyglutamic Acid Delivering an Optimized Combination of Drugs Targeting Mutated BRAF and MEK in Melanoma. Advanced Therapeutics. 3(8). 13 indexed citations
14.
Conniot, João, Anna Scomparin, Carina Peres, et al.. (2019). Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators. Nature Nanotechnology. 14(9). 891–901. 187 indexed citations
15.
Krivitsky, Adva, Vadim Krivitsky, Dina Polyak, et al.. (2018). Molecular Weight-Dependent Activity of Aminated Poly(α)glutamates as siRNA Nanocarriers. Polymers. 10(5). 548–548. 7 indexed citations
16.
Yeini, Eilam, Paula Ofek, Nir Shapir, et al.. (2018). Successful intracranial delivery of trastuzumab by gene-therapy for treatment of HER2-positive breast cancer brain metastases. Journal of Controlled Release. 291. 80–89. 22 indexed citations
17.
Markovsky, Ela, Anat Eldar‐Boock, Dikla Ben‐Shushan, et al.. (2017). Targeting NCAM-expressing neuroblastoma with polymeric precision nanomedicine. Journal of Controlled Release. 249. 162–172. 20 indexed citations
18.
Ferber, Shiran, Galia Tiram, Ana Sousa‐Herves, et al.. (2017). Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome. eLife. 6. 79 indexed citations
19.
Markovsky, Ela, Einav Vax, Dikla Ben‐Shushan, et al.. (2017). Wilms Tumor NCAM-Expressing Cancer Stem Cells as Potential Therapeutic Target for Polymeric Nanomedicine. Molecular Cancer Therapeutics. 16(11). 2462–2472. 17 indexed citations
20.
Baabur‐Cohen, Hemda, Anat Eldar‐Boock, Eilam Yeini, et al.. (2016). In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio. Journal of Controlled Release. 257. 118–131. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Galia Tiram Breakdown of academic impact, for papers by Joshua C. Doloff Breakdown of academic impact, for papers by Weilin Zhou Breakdown of academic impact, for papers by Mohammad Doroudian Breakdown of academic impact, for papers by Kamal Kant Sharma Breakdown of academic impact, for papers by Dandan Wan Breakdown of academic impact, for papers by Yajing Wen Breakdown of academic impact, for papers by Shiran Ferber Breakdown of academic impact, for papers by Shibing Wang Breakdown of academic impact, for papers by Yanhong Su
Rankless by CCL
2026